| CYSB2400160 | 人凝血因子Ⅷ | Human Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-06-21 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2400133 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2024-05-24 | | SinoCelltech Ltd | | | view |
| CYSB2400134 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2024-05-24 | | SinoCelltech Ltd | | | view |
| CYSB2400123 | 人凝血因子Ⅷ | Human Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | Supplementary Application | 2024-05-17 | | Hualan Biological Engineering Chongqing Co Ltd | | | view |
| CYSB2400124 | 人凝血因子Ⅷ | Human Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | Supplementary Application | 2024-05-17 | | Hualan Biological Engineering Chongqing Co Ltd | | | view |
| CYSB2400087 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | Supplementary Application | 2024-04-09 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2400210 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2024-04-03 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSB2400019 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-09 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JYSB2400049 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-07 | | | | | view |
| JYSB2400051 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-07 | | | | | view |
| JYSB2400050 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-07 | | | | | view |
| JYSB2400048 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-07 | | | | | view |
| CXSL2300862 | 人凝血因子Ⅷ | Human Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2023-12-15 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| JXSL2300211 | 注射用重组单链人凝血因子VIII | | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-11-28 | | | | | view |
| JXSL2300212 | 注射用重组单链人凝血因子VIII | | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-11-28 | | | | | view |
| JXSL2300213 | 注射用重组单链人凝血因子VIII | | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-11-28 | | | | | view |
| JXSL2300210 | 注射用重组单链人凝血因子VIII | | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-11-28 | | | | | view |
| JXSL2300208 | 注射用重组单链人凝血因子VIII | | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-11-28 | | | | | view |
| JXSL2300214 | 注射用重组单链人凝血因子VIII | | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-11-28 | | | | | view |
| JXSL2300209 | 注射用重组单链人凝血因子VIII | | Lyophilized | Biological Products(3.1) | Import Drug Application | 2023-11-28 | | | | | view |
